WuXi AppTec & Mayo Clinic To Jointly Develop Diagnostics
WuXi AppTec & Mayo Clinic To Jointly Develop Diagnostics
“Through this agreement, WuXi AppTec Group will have access, through an
exclusive partnership, to Mayo-developed tests and will be able to offer those
tests to hospitals, health care providers and patients in China,” said Dr.
William Morice, II, president of Mayo Medical Laboratories and chair of
Laboratory Medicine and Pathology at Mayo Clinic. “We expect this new venture
to accelerate diagnostics research in our laboratory as well, transforming
discoveries into tests that will benefit all patients.”
Dr. Jason Liu, senior vice president of WuXi AppTec Group and chief
operating officer of the company’s laboratory testing division, noted that the
collaboration is a great fit with WuXi’s mission to bring the best testing
solutions from research to clinical practice. As one of the most highly
regarded medical institutions in the world, Mayo Clinic will help WuXi
transform China’s diagnostic landscape, improve the quality of patient care and
accelerate precision medicine in China, he added.
“The strategic collaboration with Mayo Clinic is an important step
forward to fulfill WuXi AppTec Group’s dream that every drug can be made, every
disease can be treated,” said Dr. Lli Ge, chairman of WuXi AppTec Group.
“Through the collaboration with Mayo, we’re committed to building a leading
diagnostic services operation in China and co-developing in ways that will
benefit our patients, doctors and innovative collaborators in all corners of
the world.”
No comments